Imv Inc (IMV)

1.98
-0.02(-1.00%)
  • Volume:
    108,785
  • Bid/Ask:
    1.98/1.99
  • Day's Range:
    1.93 - 2.09
  • Type:Equity
  • Market:Canada
  • ISIN:CA44974L1031
  • CUSIP:44974L103

IMV Overview

Prev. Close
2
Day's Range
1.93-2.09
Revenue
370.9K
Open
2.05
52 wk Range
1.68-5.86
EPS
-0.55
Volume
108,785
Market Cap
162.64M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
80,518
P/E Ratio
-
Beta
1.82
1-Year Change
-57.96%
Shares Outstanding
82,142,629
Next Earnings Date
Mar 23, 2022
What is your sentiment on Imv Inc?
or
Market is currently closed. Voting is open during market hours.

  • IMV CFO Pierre Labbé to retire
    • BySeeking Alpha-

    Pierre Labbé, the Chief Financial Officer of IMV (IMV), will retire on March 31, 2022.An executive search firm has been hired to find a replacement

  • IMV Q3 2021 Earnings Preview
    • BySeeking Alpha-

    IMV (NASDAQ:IMV) is scheduled to announce Q3 earnings results on Thursday, November 11th, before market open.The consensus EPS Estimate is -$0.12 (+7.7% Y/Y) and the consensus...

Imv Inc Company Profile

Employees
77
Market
Canada

IMV Inc., a biopharmaceutical company, focuses on the development of cancer immunotherapies and vaccines against infectious diseases using its DPX delivery technology platform. The company’s lead drug candidate includes maveropepimut-S (DPX-Survivac), a T cell therapy, which is in three Phase II clinical trials across 6 different cancer indications with and without Merck’s Keytruda; and Phase II clinical trials for the treatment of ovarian cancer, and recurrent and refractory diffuse large B cell lymphoma. It is also developing DPX-COVID-19, a second-generation vaccine against severe acute respiratory syndrome coronavirus 2; and DPX-RSV, a vaccine candidate, which has completed Phase I clinical trials for the treatment of respiratory syncytial virus strain A, as well as DPX-SurMAGE for the treatment of bladder cancer and DPX-BRAF to treat melanoma patients. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellStrong SellStrong Sell
Technical IndicatorsSellStrong SellStrong SellStrong SellStrong Sell
SummarySellStrong SellStrong SellStrong SellStrong Sell
  • 2.7 soon
    0
    • Positive news coming out soon on Preclinical trial for Covid19 vaccine. They have introduce some virus variant/mutation in the development. Market Cap. only $300 millions.
      0
      • projections for earnings..?
        0
        • Earnings on 6th, call on 10th.
          0
          • what's next for this?
            0
            • Any new news?
              0
              • below 5....
                1
                • why though
                  0
                • I don't get it either ...
                  0
              • Absolutely Huge News Today!  The growth is just getting started
                0
                • what news
                  0
                • oh you haven't heard? I thought everyone has heard.. the bird is the word. 🎶🎶🎶🎶
                  0
                • doesn't seem to be growing...
                  0
              • what do you guys think ??
                0
                • Going back up now.... hope it breaks $5 EOD
                  0
                  • It's a trap never buy this company guys. I bought it at 6.13 and sold it at 4.4. I never saw such falling intraday  for a value vaccine company.
                    3
                    • Nison KayBy the way I don't understand how a stock can rocket on pre market and fall by 40% intraday after ? It's a bull trap move.
                      0
                    • gotta be patient
                      0
                    • yeah it's a trap I learned to never buy premarket. the volume is low so you don't really know what's going on. you should of just waited unless they do a reverse split then jump ship. unless you shorted it but the price went up so it's a lose lose.
                      0
                  • More notice about market
                    0
                    • Sell off or any bad news ?
                      0
                    • Sandeep KarwaI don't know but I sold it and took my loss, I never saw this before....
                      0
                    • it was pumped because of covid. now it's selling off because of profit takers. most likely it will have another run up before settling on a new support line.
                      0
                  • Talk about off the radar! I've got a hunch the market is going to notice today's session and react positively and swiftly I might add.
                    0
                    • A bit surprised no one is talking about this success story. Up 20% in the last few days.
                      0
                      • I couldn't agree more! I just don't get it . This stock has 10 bagger potential it's no pump & dump it is in a true breakout out pattern. Talk about under the radar!
                        0
                    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.